Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Marc De Man"'
Autor:
Amélie Deleporte, Marc Van den Eynde, Frédéric Forget, Stéphane Holbrechts, Thierry Delaunoit, Ghislain Houbiers, Hassan R. Kalantari, Stéphanie Laurent, Erik Vanderstraeten, Marc De Man, Philippe Vergauwe, Marylene Clausse, Jacques Van Der Auwera, Lionel D’Hondt, Pascal Pierre, Bjorn Ghillemijn, Angelique Covas, Marianne Paesmans, Lieveke Ameye, Ahmad Awada, Francesco Sclafani, Alain Hendlisz
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4366-4374 (2021)
Abstract Background While docetaxel/cisplatin/5‐fluorouracil (DCF) outperforms CF in first‐line gastric adenocarcinoma, toxicity remains an issue. Methods This multicenter phase II trial randomized chemonaïve metastatic gastric adenocarcinoma pa
Externí odkaz:
https://doaj.org/article/06c577acc47b4f5695fc7987fb553200
Autor:
Eduard Callebout, Suzane Moura Ribeiro, Stephanie Laurent, Marc De Man, Liesbeth Ferdinande, Kathleen B. M. Claes, Joni Van der Meulen, Karen P. Geboes
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background Non-V600E BRAF mutated colorectal cancer (CRC) is a rare disease entity with specific clinical features. These tumors are less likely to have microsatellite instability than CRC with a V600E BRAF mutation and often harbor a KRAS o
Externí odkaz:
https://doaj.org/article/50ab91e4159a4e8d9c1905f60e08bb87
Autor:
Evi Mampaey, Annelies Fieuw, Thalia Van Laethem, Liesbeth Ferdinande, Kathleen Claes, Wim Ceelen, Yves Van Nieuwenhove, Piet Pattyn, Marc De Man, Kim De Ruyck, Nadine Van Roy, Karen Geboes, Stéphanie Laurent
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0131421 (2015)
BACKGROUND:With one million new cases of colorectal cancer (CRC) diagnosed annually in the world, CRC is the third most commonly diagnosed cancer in the Western world. Patients with stage I-III CRC can be cured with surgery but are at risk for recurr
Externí odkaz:
https://doaj.org/article/c25ec89b0867462d818a158d516e3ba9
Autor:
Marc De Man, Pascal Pierre, Erik Vanderstraeten, Ghislain Houbiers, Lionel D'Hondt, Jacques Van Der Auwera, Hassan Rezaei Kalantari, Amélie Deleporte, Ahmad Awada, Lieveke Ameye, Alain Hendlisz, Thierry Delaunoit, Stéphanie Laurent, Francesco Sclafani, Bjorn Ghillemijn, Marylene Clausse, Marianne Paesmans, Angelique Covas, Marc Van den Eynde, Frédéric Forget, Philippe Vergauwe, Stéphane Holbrechts
Publikováno v:
Cancer medicine, Vol. 10, no. 13, p. 4366-4374 (2021)
Cancer Medicine, Vol 10, Iss 13, Pp 4366-4374 (2021)
Cancer Medicine
Cancer Medicine, Vol 10, Iss 13, Pp 4366-4374 (2021)
Cancer Medicine
Background While docetaxel/cisplatin/5‐fluorouracil (DCF) outperforms CF in first‐line gastric adenocarcinoma, toxicity remains an issue. Methods This multicenter phase II trial randomized chemonaïve metastatic gastric adenocarcinoma patients to
Autor:
MARC DE MAN
Publikováno v:
Estudios de derecho marítimo. Libro en homenaje a la memoria de José Luis Goñi Etchevers ISBN: 9789587908114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1107409b9a2bcd3ac534f24404f33e37
https://doi.org/10.2307/j.ctv2svjsk2.12
https://doi.org/10.2307/j.ctv2svjsk2.12
Autor:
Roos Colman, Eline Naert, Simon Van Belle, Veerle Surmont, Karen Geboes, Kim Eecloo, Luc Deliens, Martine De Laat, Marc De Man, Koen Pardon, Gaëlle Vanbutsele
Publikováno v:
European Journal of Cancer. 124:186-193
Purpose This study evaluated the effect of early integrated palliative care (PC) in oncology on quality of life (QOL) near the end of life and use of health care resources near the end of life. Method Patients with advanced cancer and a life expectan
Publikováno v:
Journal of Vascular and Interventional Radiology. 31:82-92
To prove that covered stents are more efficacious than uncovered stents regarding patency, safety, enabling of chemotherapy, and survival in percutaneous palliation of malignant infrahilar biliary obstruction.After failed endoscopic treatment, 154 pa
Publikováno v:
Acta clinica Belgica. 76(3)
We describe a case of a 59-year-old man without relevant past medical history, presenting with chronic diarrhea and weight loss. Extensive laboratory analysis, stool cultures and gastro- and ileocolonoscopy could not identify a diagnosis. Abdominal i
Autor:
Liesbeth Ferdinande, Piet Ost, Lieve Brochez, Vibeke Kruse, Dirk Van de Putte, Ines Chevolet, Annabel Meireson, Marc De Man, Eva Hulstaert, Laurine Verset, Pieter Demetter, Karen Geboes
Publikováno v:
Oncotarget
ONCOTARGET
Oncotarget, 9 (38
ONCOTARGET
Oncotarget, 9 (38
Targeting immune checkpoint molecules has become a major new strategy in the treatment of several cancers. Indoleamine 2,3-dioxygenase (IDO)-inhibitors are a potential next-generation immunotherapy, currently investigated in multiple phase I-III tria
Publikováno v:
Acta Clinica Belgica. 73:251-256
Background Anemia is frequent in patients with cancer and is often multifactorial. Treatment depends on etiology and can consist of transfusions, intravenous iron (IV Fe), and/or erythropoiesis-stimulating agents (ESA). Several studies have shown tha